Ajooni Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
For the six months, sales was INR 342.38 million compared to INR 219.42 million a year ago. Revenue was INR 342.55 million compared to INR 219.49 million a year ago. Net income was INR 6.66 million compared to INR 3.89 million a year ago. Basic earnings per share from continuing operations was INR 0.134 compared to INR 0.0828 a year ago. Diluted earnings per share from continuing operations was INR 0.134 compared to INR 0.0828 a year ago.